216 related articles for article (PubMed ID: 16229374)
1. [Pathophysiology and treatment of the overactive bladder syndrome in an aged male patient with voiding difficulty: pharmacological treatment].
Akino H
Hinyokika Kiyo; 2005 Sep; 51(9):609-13. PubMed ID: 16229374
[TBL] [Abstract][Full Text] [Related]
2. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
Gotoh M
Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
[TBL] [Abstract][Full Text] [Related]
3. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
Lee JY; Kim HW; Lee SJ; Koh JS; Suh HJ; Chancellor MB
BJU Int; 2004 Oct; 94(6):817-20. PubMed ID: 15476515
[TBL] [Abstract][Full Text] [Related]
4. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
Sriplakich S; Promwatcharanon K
J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
[TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
Liu HT; Kuo HC
Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
[TBL] [Abstract][Full Text] [Related]
6. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
[TBL] [Abstract][Full Text] [Related]
7. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
[TBL] [Abstract][Full Text] [Related]
9. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
11. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
Chapple CR; Roehrborn CG
Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
13. ["Pathophysiology and treatment of the overactive bladder"].
Yokoyama O
Hinyokika Kiyo; 2005 Sep; 51(9):599-601. PubMed ID: 16229372
[TBL] [Abstract][Full Text] [Related]
14. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis and therapy examined under the microscope. LUTS (lower urinary tract symptoms) due to OAB (overactive bladder) - a frequent disease picture in the man].
MMW Fortschr Med; 2011 Mar; 153(13):44-5. PubMed ID: 21638816
[No Abstract] [Full Text] [Related]
16. Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Patel AK; Chapple CR
Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417
[TBL] [Abstract][Full Text] [Related]
17. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.
Hanuš T; Zámečník L; Doležal T; Karmazínová Z
Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947
[TBL] [Abstract][Full Text] [Related]
19. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
20. [Medical treatment of voiding problems in men].
Andersen JT; Nordling J; Walter S
Ugeskr Laeger; 2007 May; 169(20):1892-4. PubMed ID: 17553364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
